Table 2.
Best-Corrected Visual Acuity and CSFT of the Study Eye
| BCVA, Letters | Baseline | Month 2 | Month 6 | Month 12 |
| Adolescent patients | ||||
| A | 34 | 47 | 51* | 55 |
| B | 82 | 84 | 91 | 87 |
| C | 63 | 73 | 77 | 77 |
| D | 65 | 71 | 73 | 70 |
| E | 46 | 61 | 81 | 84 |
| Change in BCVA from baseline, letters | ||||
| Mean | +9.2 | +16.6 | +16.6 | |
| Min–max | +2 to +15 | +8 to +35 | +5 to +38 |
| CSFT, μm | Baseline | Month 2 | Month 6 | Month 12 |
| Adolescent patients | ||||
| A | 696 | 481 | 501* | 490 |
| B | 216 | 220 | 222 | 226 |
| C | 245 | 246 | 247 | 254 |
| D | 451 | 529 | 453 | 342 |
| E | 520 | 495 | 267 | 234 |
| Change in CSFT from baseline, μm | ||||
| Mean | −31.4 | −87.6 | −116.4 | |
| Min–max | −215 to +78 | −253 to +6 | −286 to +10 |
Optical coherence tomography data for the study eye, as assessed by the CRC.
Month-7 visit data reported here, as Month-6 visit was not reported for this patient.